NCT00753740 2020-06-12Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.Lumos PharmaPhase 2 Withdrawn
NCT01384877 2019-07-12Subcutaneous Lidocaine For Cancer-Related PainBritish Columbia Cancer AgencyPhase 2/3 Completed33 enrolled 16 charts